LifeCodexx En Route to Launching Sequencing-Based Trisomy 21 Test by Year End

LifeCodexx recently completed a pilot study of 45 patients on Illumina's Genome Analyzer, but plans to switch to the HiSeq 2000 for a clinical validation study and for the commercial version of the test.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.